Close

Celularity Tissue Factor Gene Knockout of Allogeneic Stromal Cells Significantly Lowers Thrombotic Effects; Study Highlights Critical Importance of Gene Editing Capability

Go back to Celularity Tissue Factor Gene Knockout of Allogeneic Stromal Cells Significantly Lowers Thrombotic Effects; Study Highlights Critical Importance of Gene Editing Capability
(NASDAQ: CELU) Delayed: 3.97 -0.23 (5.48%)
Previous Close $4.20    52 Week High
Open $4.07    52 Week Low
Day High $4.41    P/E N/A 
Day Low $3.85    EPS
Volume 22,333